Avid Bioservices Inc.

(CDMO) Trade

By |

Profile

Avid Bioservices Inc is a clinical-stage biopharmaceutical company focused on development and current Good Manufacturing Practices (cGMP) of biopharmaceutical products derived from mammalian cell culture. The company provides a comprehensive range of process development, high quality cGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries.

Contact Information

Website: www.avidbio.com
Email: sdiaz@vidasp.com
Main Phone: +1 714 508-6100
Address: 2642 Michelle Drive
Address 2: Suite 200
State: CA
City / Town: Tustin
Country: US
Postal Code: 92780

Issuer Information

Exchange: NSC
CEO: Nicholas S. Green
Employees: 227
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

Profile

Avid Bioservices Inc is a clinical-stage biopharmaceutical company focused on development and current Good Manufacturing Practices (cGMP) of biopharmaceutical products derived from mammalian cell culture. The company provides a comprehensive range of process development, high quality cGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries.

Contact Information

Website: www.avidbio.com
Email: sdiaz@vidasp.com
Main Phone: +1 714 508-6100
Address: 2642 Michelle Drive
Address 2: Suite 200
State: CA
City / Town: Tustin
Country: US
Postal Code: 92780

Issuer Information

Exchange: NSC
CEO: Nicholas S. Green
Employees: 227
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

$ 18.95 $ 0.35 (1.88%)
Last Price 18.95 Change $ 0.35 Change % 1.88 Tick N/A
Bid 18.90 Bid Size 10,000.00 Ask 19.29 Ask Size 100.00
Open 19.00 High 19.33 Low 18.50 Prev Close 18.60
Last Trade Volume 722,346 52 Wk Hi 19.36 52 Wk Low 3.02
Market Cap 1.1 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 60,559,669.00 EPS (TTM) -0.09 PE Ratio -198.80 Exchange NCM
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 13
Number of Buys 0 13
Number of Sells 0 0
Net Activity 0 198590
Last 10 Buys Shares
Joel McComb 1,000
Joseph Carleone 1,000
Mark R. Bamforth 1,000
Mark R. Bamforth 1,000
Mark R. Bamforth 1,000
Mark R. Bamforth 1,000
Mark R. Bamforth 1,000
Mark R. Bamforth 1,000
Mark R. Bamforth 1,000
Mark R. Bamforth 1,000
Last 10 Sell Shares
N/A 0
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 5 10 10 5
Low Target Price Estimate 4 4 4 4
Mean Target Price Estimate 4.5 6.33 7 4.5
Standard Deviation 0.71 3.21 4.24 0.71
Date of Most Recent Estimate 05/24/18 05/24/18 03/14/18 05/24/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 2 1 1 3
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1